PET and MR Imaging: The Odd Couple or a Match Made in Heaven?
暂无分享,去创建一个
[1] W. Cullen,et al. Research confuses me: what is the difference between case-control and cohort studies in quantitative research? , 2013, Irish medical journal.
[2] Arno Villringer,et al. Physical and organizational provision for installation, regulatory requirements and implementation of a simultaneous hybrid PET/MR-imaging system in an integrated research and clinical setting , 2013, Magnetic Resonance Materials in Physics, Biology and Medicine.
[3] Eveliina Arponen,et al. Improved detection of localized prostate cancer using co-registered MRI and 11C-acetate PET/CT. , 2012, European journal of radiology.
[4] Markus Schwaiger,et al. Workflow and Scan Protocol Considerations for Integrated Whole-Body PET/MRI in Oncology , 2012, The Journal of Nuclear Medicine.
[5] Bruce R. Rosen,et al. fMRI at 20: Has it changed the world? , 2012, NeuroImage.
[6] Ciprian Catana,et al. MRI-Based Nonrigid Motion Correction in Simultaneous PET/MRI , 2012, The Journal of Nuclear Medicine.
[7] C. Arango,et al. Autism Spectrum Disorder: Does Neuroimaging Support the DSM-5 Proposal for a Symptom Dyad? A Systematic Review of Functional Magnetic Resonance Imaging and Diffusion Tensor Imaging Studies , 2011, Journal of Autism and Developmental Disorders.
[8] C. Kuhl,et al. MRI-Based Attenuation Correction for Hybrid PET/MRI Systems: A 4-Class Tissue Segmentation Technique Using a Combined Ultrashort-Echo-Time/Dixon MRI Sequence , 2012, The Journal of Nuclear Medicine.
[9] R. Shah,et al. Introducing Parametric Fusion PET/MRI of Primary Prostate Cancer , 2012, The Journal of Nuclear Medicine.
[10] E. Matsusue,et al. Correlation of apparent diffusion coefficients measured by diffusion-weighted MR imaging and standardized uptake values from FDG PET/CT in metastatic neck lymph nodes of head and neck squamous cell carcinomas. , 2012, Clinical imaging.
[11] Yan Yin,et al. 18F-FDG PET, combined FDG-PET/CT and MRI for evaluation of bone marrow infiltration in staging of lymphoma: a systematic review and meta-analysis. , 2012, European journal of radiology.
[12] T Schaeffter,et al. Thoracic respiratory motion estimation from MRI using a statistical model and a 2-D image navigator , 2012, Medical Image Anal..
[13] G. Delso,et al. Performance Measurements of the Siemens mMR Integrated Whole-Body PET/MR Scanner , 2011, The Journal of Nuclear Medicine.
[14] T. Kwee,et al. Is MRI less accurate than FDG-PET/CT in diagnosing bone marrow involvement in lymphoma? , 2011, European journal of radiology.
[15] W. Nishio,et al. N stage disease in patients with non-small cell lung cancer: efficacy of quantitative and qualitative assessment with STIR turbo spin-echo imaging, diffusion-weighted MR imaging, and fluorodeoxyglucose PET/CT. , 2011, Radiology.
[16] M. Bandstra,et al. Measurements of Fukushima fallout by the Berkeley Radiological Air and Water Monitoring project , 2011, 2011 IEEE Nuclear Science Symposium Conference Record.
[17] Z. Fayad,et al. MRI-based motion correction of thoracic PET: initial comparison of acquisition protocols and correction strategies suitable for simultaneous PET/MRI systems , 2011, European Radiology.
[18] Jason S. Lewis,et al. The next generation of positron emission tomography radiopharmaceuticals in oncology. , 2011, Seminars in nuclear medicine.
[19] H. Zaidi,et al. Design and performance evaluation of a whole-body Ingenuity TF PET–MRI system , 2011, Physics in medicine and biology.
[20] Wendy Y. Zhang,et al. Imaging Cardiac Stem Cell Therapy: Translations to Human Clinical Studies , 2011, Journal of cardiovascular translational research.
[21] S. Voss. Pediatric oncology and the future of oncological imaging , 2011, Pediatric Radiology.
[22] T. Leiner,et al. Accuracy of Gadofosveset-enhanced MRI for Nodal Staging and Restaging in Rectal Cancer , 2011, Annals of surgery.
[23] Ciprian Catana,et al. Bimodal thrombus imaging: simultaneous PET/MR imaging with a fibrin-targeted dual PET/MR probe--feasibility study in rat model. , 2011, Radiology.
[24] Michael Souvatzoglou,et al. Radionuclide and hybrid imaging of recurrent prostate cancer. , 2011, The Lancet. Oncology.
[25] Ciprian Catana,et al. MRI-Assisted PET Motion Correction for Neurologic Studies in an Integrated MR-PET Scanner , 2011, The Journal of Nuclear Medicine.
[26] K-J Langen,et al. High resolution BrainPET combined with simultaneous MRI , 2011, Nuklearmedizin.
[27] C. Czerny,et al. Functional imaging in head and neck squamous cell carcinoma: correlation of PET/CT and diffusion-weighted imaging at 3 Tesla , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[28] R. Weissleder,et al. MRI with Magnetic Nanoparticles Monitors Downstream Anti-Angiogenic Effects of mTOR Inhibition , 2011, Molecular Imaging and Biology.
[29] J. Stoker,et al. Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment. , 2010, Radiology.
[30] Ciprian Catana,et al. Toward Implementing an MRI-Based PET Attenuation-Correction Method for Neurologic Studies on the MR-PET Brain Prototype , 2010, The Journal of Nuclear Medicine.
[31] C. Franzius. FDG-PET/CT in pediatric solid tumors. , 2010, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....
[32] Dieter Renker,et al. Evaluation of Geiger-mode APDs for PET block detector designs , 2010, Physics in medicine and biology.
[33] A. Alavi,et al. Non-FDG PET in the practice of oncology. , 2010, Indian journal of cancer.
[34] Ciprian Catana,et al. Bimodal MR-PET agent for quantitative pH imaging. , 2010, Angewandte Chemie.
[35] V. Torri,et al. Performance of imaging modalities in diagnosis of liver metastases from colorectal cancer: A systematic review and meta‐analysis , 2010, Journal of magnetic resonance imaging : JMRI.
[36] R. Günther,et al. Automatic, three-segment, MR-based attenuation correction for whole-body PET/MR data , 2010, European Journal of Nuclear Medicine and Molecular Imaging.
[37] Keith A. Johnson,et al. Functional Alterations in Memory Networks in Early Alzheimer’s Disease , 2010, NeuroMolecular Medicine.
[38] Paul Kinahan,et al. Weight-Based, Low-Dose Pediatric Whole-Body PET/CT Protocols , 2009, Journal of Nuclear Medicine.
[39] I. Steffen,et al. Early and late therapy response assessment with [18F]fluorodeoxyglucose positron emission tomography in pediatric Hodgkin's lymphoma: analysis of a prospective multicenter trial. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[40] F. Fahey. Dosimetry of Pediatric PET/CT* , 2009, Journal of Nuclear Medicine.
[41] J. Eary,et al. [F‐18]‐fluorodeoxy‐D‐glucose–positron emission tomography response is associated with outcome for extremity osteosarcoma in children and young adults , 2009, Cancer.
[42] McCarville Mb. PET-CT imaging in pediatric oncology. , 2009 .
[43] M. B. McCarville,et al. PET-CT imaging in pediatric oncology , 2009, Cancer imaging : the official publication of the International Cancer Imaging Society.
[44] H. Mayberg. Targeted electrode-based modulation of neural circuits for depression. , 2009, The Journal of clinical investigation.
[45] Nassir Navab,et al. Tissue Classification as a Potential Approach for Attenuation Correction in Whole-Body PET/MRI: Evaluation with PET/CT Data , 2009, Journal of Nuclear Medicine.
[46] Jin Hwan Kim,et al. CT, MR, US, 18F-FDG PET/CT, and their combined use for the assessment of cervical lymph node metastases in squamous cell carcinoma of the head and neck , 2009, European Radiology.
[47] Stephan G. Nekolla,et al. PET and MRI in cardiac imaging: from validation studies to integrated applications , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[48] H. Amièva,et al. Prodromal Alzheimer's disease: Successive emergence of the clinical symptoms , 2008, Annals of neurology.
[49] Bernhard Schölkopf,et al. MRI-Based Attenuation Correction for PET/MRI: A Novel Approach Combining Pattern Recognition and Atlas Registration , 2008, Journal of Nuclear Medicine.
[50] E. Robbins,et al. Radiation risks from imaging studies in children with cancer , 2008, Pediatric blood & cancer.
[51] Ignace Lemahieu,et al. MR-based attenuation correction for PET using an Ultrashort Echo Time (UTE) sequence , 2008, 2008 IEEE Nuclear Science Symposium Conference Record.
[52] C. Claussen,et al. Simultaneous Mr/pet Imaging of the Human Brain: Feasibility Study 1 , 2022 .
[53] Chenjie Xu,et al. PET/MRI Dual-Modality Tumor Imaging Using Arginine-Glycine-Aspartic (RGD)–Conjugated Radiolabeled Iron Oxide Nanoparticles , 2008, Journal of Nuclear Medicine.
[54] Benjamin R. Jarrett,et al. Synthesis of 64Cu-labeled magnetic nanoparticles for multimodal imaging. , 2008, Bioconjugate chemistry.
[55] In Chan Song,et al. An Investigation Into the Use of Geiger-Mode Solid-State Photomultipliers for Simultaneous PET and MRI Acquisition , 2008, IEEE Transactions on Nuclear Science.
[56] J. Baron,et al. Relationships between Hippocampal Atrophy, White Matter Disruption, and Gray Matter Hypometabolism in Alzheimer's Disease , 2008, The Journal of Neuroscience.
[57] Hans Herzog,et al. Template-based attenuation correction of PET in hybrid MR-PET scanners , 2008 .
[58] C. Jack,et al. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. , 2008, Brain : a journal of neurology.
[59] 徳原 孝哉. Evaluation of lymph node metastases in gastric cancer using magnetic resonance imaging with ultrasmall superparamagnetic iron oxide (USPIO) : diagnostic performance in post-contrast images using new diagnostic criteria , 2008 .
[60] Y. Tsushima,et al. Clinicopathological presentation of varying 18F-FDG uptake and expression of glucose transporter 1 and hexokinase II in cases of hepatocellular carcinoma and cholangiocellular carcinoma , 2008, Annals of nuclear medicine.
[61] I. Narabayashi,et al. Evaluation of lymph node metastases in gastric cancer using magnetic resonance imaging with ultrasmall superparamagnetic iron oxide (USPIO): diagnostic performance in post-contrast images using new diagnostic criteria , 2008, Gastric Cancer.
[62] Rika Takikawa,et al. [In-vivo visualization of gene expression using magnetic resonance imaging]. , 2007, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.
[63] H. Jadvar,et al. PET and PET/CT in pediatric oncology. , 2007, Seminars in nuclear medicine.
[64] J. Drevs,et al. Phase I clinical study of AZD2171, an oral vascular endothelial growth factor signaling inhibitor, in patients with advanced solid tumors. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[65] Gerald Q. Maguire,et al. Improving Specificity of Breast MRI Using Prone PET and Fused MRI and PET 3D Volume Datasets , 2007, Journal of Nuclear Medicine.
[66] Mitchell D Schnall,et al. Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Assessing Tumor Vascularity and Vascular Effects of Targeted Therapies in Renal Cell Carcinoma , 2007, Clinical Cancer Research.
[67] 이재성,et al. An investigation into the use of Geiger-mode solid-state photomultipliers for simultaneous PET and MRI acquisition , 2007 .
[68] J. Fütterer,et al. Use of ultrasmall superparamagnetic iron oxide in lymph node MR imaging in prostate cancer patients. , 2007, European journal of radiology.
[69] Tracy T Batchelor,et al. AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. , 2007, Cancer cell.
[70] T. Helbich,et al. Axillary lymph node metastases in patients with breast carcinomas: assessment with nonenhanced versus uspio-enhanced MR imaging. , 2006, Radiology.
[71] M. Robson,et al. Clinical ultrashort echo time imaging of bone and other connective tissues , 2006, NMR in biomedicine.
[72] Alda Pinto,et al. USPIO‐enhanced magnetic resonance imaging for nodal staging in patients with head and neck cancer , 2006, Journal of magnetic resonance imaging : JMRI.
[73] Kevin Camphausen,et al. Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[74] Jingxian Shen,et al. Evaluation of lymph node metastases in gastric cancer with spiral computed tomography , 2006 .
[75] Benjamin J. Shannon,et al. Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory , 2005, The Journal of Neuroscience.
[76] Matthew D Robson,et al. Magnetic resonance imaging of cortical bone with ultrashort TE pulse sequences. , 2005, Magnetic resonance imaging.
[77] Habib Zaidi,et al. Atlas-guided non-uniform attenuation correction in cerebral 3D PET imaging , 2005, NeuroImage.
[78] David W Townsend,et al. PET/CT today and tomorrow. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[79] M. Schwaiger,et al. Performance test of a LSO-APD PET module in a 9.4 Tesla magnet , 1997, 1997 IEEE Nuclear Science Symposium Conference Record.
[80] S. Cherry,et al. Simultaneous PET and MR imaging , 1997, Physics in medicine and biology.
[81] J. Barendregt,et al. Global burden of disease , 1997, The Lancet.